Shire plc, SHPG is in the exchange NASDAQ and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in Ireland, Shire plc, SHPG has a market cap of 56643.68. Since its IPO date on the 3/25/1998, Shire plc, SHPG performance year to date is -7.80%. Today Shire plc, SHPG has gained -0.69%, with a current price of 188.21.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 29.10%. The management of the company have seen the company have a payout ratio of 10.00%. Return of assets are at 7.00%, with return on investment at 12.00%.
In terms of debt levels and profit levels, Shire plc, SHPG is seeing a long-term debt/equity of 0.45. While Total debt/equity is 0.67. With a profit margin of 19.80%, this is combined with a gross margin of 85.10%, and operating margin of 22.40%. Shire plc ability to meet debt levels, with a current ratio of 0.6, while the quick ratio is 0.4.
For the last year Shire plc, SHPG has seen a EPS growth of -59.40%. A performance for the year of -22.17%. The 52-week high is -30.12%, and the 52-week low is 28.05%. The average volume for Shire plc, SHPG is 1019489.
With a target price of 241.86, can Shire plc, SHPG reach this target? Looking at the value indicators of Shire plc, SHPG. Shire plc has a P/E of 27.9 and a forward P/E of 12.55. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.45. Shire plc also has a P/S and a P/B of 8.53 and 3.61 respectively. For P/cash, Shire plc has a value of 820.92, while it is *TBA for P/free cash flow.
At the current price of 188.21, Shire plc has a dividend yield of 0.71%. We see a return on equity of 13.50%.
Looking more long-term Shire plc, is projected to get an EPS growth for the next five years of 11.40%. In the short-term an EPS growth of 19.55% in the next year is forecasted. This is after a EPS growth of -59.40% for this year and for the last five years a 16.50% growth has been seen.